Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maimendong Decoction (also known as Mai Men Dong Tang) is a classic Traditional Chinese Medicine (TCM) formula originally described in the *Synopsis of Prescriptions of the Golden Chamber* (Jin Gui Yao Lue). It is primarily used to treat conditions characterized by lung and stomach yin deficiency and rebellious qi. The formula typically consists of six herbal ingredients: *Ophiopogon japonicus* (the sovereign herb), *Pinellia ternata*, *Panax ginseng*, *Glycyrrhiza uralensis*, *Oryza sativa*, and *Ziziphus jujuba*. In modern clinical research, it is evaluated for its efficacy in treating respiratory conditions such as chronic bronchitis and dry cough, as well as gastrointestinal disorders like reflux esophagitis, particularly when classified under the TCM pattern of stomach heat and yin deficiency. Its pharmacological actions include nourishing yin, moistening the lungs, protecting the esophageal and gastric mucosa, and regulating gastrointestinal motility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maimendong decoction.